Abstract:Integrin aVb3 is a prominent member of the "RGD-recognizing" integrin family of cell surface receptors. aVb3 binds to various extracellular matrix (ECM) proteins and oxysterols such as 25-hydroxycholesterol, is implicated in several diseases, including cancer metastasis, lung fibrosis, inflammation, and autoimmune diseases, and is pursued as a valuable therapeutic target. Despite enormous efforts to seek a pure antagonist, to date, no single drug candidate has successfully reached clinics due to associated partial agonism and toxicity issues. Developing effective and safe inhibitors require a thorough understanding of the molecular interactions and structural changes related to the receptor's activation and inhibition mechanisms. This study offers a comprehensive residue-residue contact and network analyses of the ligand-binding beta-propeller alpha-I domains (headpiece) based on all available experimental structures of integrin aVb3 in unliganded, agonist-, antagonist-, and antibody-bound states. The analyses reveal many critical interactions that were not reported before and show that specific orientation and interactions of residues from the specificity-determining loop (SDL) are critical in molecular recognition and regulation. Also, the network analysis reveals that residues from the nearby allosteric site (site II) connect to the primary RGD-binding site via SDL, which likely acts as an interface between the two sites. Our results provide valuable insights into molecular interactions, structural changes, distinct features of the active and inactive headpiece conformations, the role of SDL in ligand recognition, and SDL-mediated allostery. Thus, the insights from this study may facilitate the designing of pure antagonists or site II-mediated allosteric modulators to integrin aVb3 to treat various diseases.

Interaction between integrin α IIb β 3 and synthesized cyclic hexapeptide containing RGD

Interaction Between Integrin Alpha(Iib)Beta(3) and Synthesized Cyclic Hexapeptide Containing Rgd

Intervesicle Cross-Linking with Integrin Alpha IIb Beta 3 and Cyclic-Rgd-lipopeptide. A Model of Cell-Adhesion Processes.

Specific binding of integrin αIIbβ3 to RGD peptide: A surface plasmon resonance study

An RGD-Containing Peptide Derived from Wild Silkworm Silk Fibroin Promotes Cell Adhesion and Spreading

Interaction Mechanism and Clustering among Rgd Peptides and Integrins

Molecular Basis For The Targeted Binding Of Rgd-Containing Peptide To Integrin Alpha(V)Beta(3)

Specific detection of integrin αvβ3 by light-up bioprobe with aggregation-induced emission characteristics.

Specific Detection Of Integrin Alpha(V)Beta(3) By Light-Up Bioprobe With Aggregation-Induced Emission Characteristics

Molecular basis for the targeted binding of RGD-containing peptide to integrin αVβ3.

Specific Binding of Integrin Αiibβ3 to RGD Peptide Immobilized on a Nitrilotriacetic Acid Chip: a Surface Plasmon Resonance Study

Engineering integrin-specific surfaces with a triple-helical collagen-mimetic peptide

Effect of amino acids near the RGD sequence on binding activities between αIIbβ3 integrin and fibrinogen in the presence of RGD-containing synthetic peptides from elegantin and angustatin

A New Cyclic RGD Peptide Dimer for Integrin Αvβ3 Imaging.

Application of cysteinyl prolyl ester for the synthesis of cyclic peptides containing an RGD sequence and their biological activity measurement

Structural insights into the molecular recognition of integrin αVβ3 by RGD-containing ligands: The role of the specificity-determining loop (SDL)

Design, Activity Determination and 99mtc Labeling of Cyclic RGD Dimer for Targeting Integrin Αvβ3

Molecular Simulation Studies on a Zwitterionic Peptide-Dendrimer Conjugate for Integrin Αvβ3 Binding.

New Method of Immobilizing RGD Onto Porous-Titanium Surface

Immobilization of RGD Peptide on HA Coating Through a Chemical Bonding Approach.

Integrin Facilitates the Internalization of TAT Peptide Conjugated to RGD Motif in Model Lipid Membranes